Universe Pharmaceuticals Stock Alpha and Beta Analysis
| UPC Stock | USD 1.72 0.09 4.97% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Universe Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Universe Pharmaceuticals over a specified time horizon. Remember, high Universe Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Universe Pharmaceuticals' market risk premium analysis include:
Beta 0.0797 | Alpha (3.75) | Risk 12.93 | Sharpe Ratio (0.30) | Expected Return (3.85) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Universe |
Universe Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Universe Pharmaceuticals market risk premium is the additional return an investor will receive from holding Universe Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Universe Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Universe Pharmaceuticals' performance over market.| α | -3.75 | β | 0.08 |
Universe Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Universe Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Universe Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Universe Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how Universe Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Universe Pharmaceuticals shares will generate the highest return on investment. By understating and applying Universe Pharmaceuticals stock market price indicators, traders can identify Universe Pharmaceuticals position entry and exit signals to maximize returns.
Universe Pharmaceuticals Return and Market Media
The median price of Universe Pharmaceuticals for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 4.2 with a coefficient of variation of 139.9. The daily time series for the period is distributed with a sample standard deviation of 15.94, arithmetic mean of 11.39, and mean deviation of 11.99. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Universe Pharmaceuticals GAAP EPS of -3.59, revenue of 12.88M | 09/20/2024 |
2 | UPCX Self Reported Market Capitalization Reaches 1.32 Million | 10/22/2024 |
3 | UPCX Hits 24 Hour Volume of 1.79 Million | 10/28/2024 |
4 | Universe Pharmaceuticals receives non-compliance letter from Nasdaq | 11/01/2024 |
5 | UPCX Trading Down 2.3 percent Over Last 7 Days | 11/06/2024 |
6 | Universe Pharmaceuticals Inc trading halted, news pending - TipRanks | 11/15/2024 |
7 | Universe Pharmaceuticals stock hits 52-week low at 1.78 By Investing.com - Investing.com Australia | 11/21/2024 |
About Universe Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Universe or other stocks. Alpha measures the amount that position in Universe Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Dividend Yield | 0.009169 | 0.009627 | Price To Sales Ratio | 1.84 | 1.75 |
Universe Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Universe Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Universe Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Universe Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Universe Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Universe Pharmaceuticals' management manipulating its earnings.
| 9th of February 2024 Upcoming Quarterly Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View |
Build Portfolio with Universe Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Universe Pharmaceuticals Backtesting, Universe Pharmaceuticals Valuation, Universe Pharmaceuticals Correlation, Universe Pharmaceuticals Hype Analysis, Universe Pharmaceuticals Volatility, Universe Pharmaceuticals History and analyze Universe Pharmaceuticals Performance. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Universe Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.